Aurinia Pharmaceuticals Inc. - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Aurinia Pharmaceuticals Inc. on February 29, 2016. The registrant is a foreign private issuer reporting pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The filing serves to distribute a news release regarding the company's scheduled presentation at the 36th Annual Cowan Health Care Conference.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing referencing a corporate event rather than a financial report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The content is limited to the announcement of an upcoming investor conference presentation.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The sole substantive item is the confirmation of the company's participation in the 36th Annual Cowan Health Care Conference.
Key Facts for Investors to Verify
- Verify the date and agenda of the 36th Annual Cowan Health Care Conference to assess the timing of the company's presentation.
- Review the actual news release (Exhibit 99.1) referenced in the filing for any specific details regarding the presentation content.
- Consult the company's most recent Form 20-F or Form 40-F for current financial performance data, as this Form 6-K does not contain financial statements.